Avinger operates as a commercial-stage medical equipment company that invents and produces the original and exclusive image-guided, catheter-based system for addressing patients with Peripheral Artery Disease (PAD). It is estimated that PAD impacts more than 12 million individuals in the United States and over 200 million globally. Avinger is committed to revolutionizing the approach to treating vascular disease with its Lumivascular platform, currently comprising the Lightbox imaging console, the Ocelot and Tigereye™ line of chronic total occlusion (CTO) catheters, and the Pantheris® line of atherectomy devices.
Avinger
Headquarters
United States of America